Bruce Kovner, Director, 10% Owner at SYNTA PHARMACEUTICALS CORP (SNTA), sold 5,436,673 shares at $0.47 ($3.0M) on 2015-11-12, disclosed to the SEC on 2015-11-12.
Seasonal sale ($3.0M) by Director, 10% Owner — this insider has traded SNTA in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.61 | 2,225,054 | $1.4M | 45.1% |
| 2 | $0.55 | 1,397,114 | $768K | 25.5% |
| 3 | $0.50 | 1,080,941 | $540K | 18.0% |
| 4 | $0.47 | 733,564 | $345K | 11.5% |
| Total | $0.55 avg | 5,436,673 | $3.0M | 100% |
| Filing → |
| SBBP | BUY | 2018-12-21 | $1.3M | — | Filing → |
| SBBP | BUY | 2018-08-09 | $3.6M | — | Filing → |
| SBBP | BUY | 2018-07-27 | $2.6M | — | Filing → |